Astrazeneca Plc
(AZN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,773,000 | 6,529,000 | 3,402,000 | 8,691,000 | 7,025,000 |
| Depreciation Amortization | 4,222,000 | 2,673,000 | 1,284,000 | 6,688,000 | 4,351,000 |
| Accounts receivable | N/A | N/A | N/A | -1,624,000 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 862,000 | N/A |
| Other Working Capital | 64,000 | -771,000 | -426,000 | -893,000 | -543,000 |
| Other Operating Activity | -1,826,000 | -1,332,000 | -547,000 | -1,863,000 | -1,879,000 |
| Operating Cash Flow | $12,233,000 | $7,099,000 | $3,713,000 | $11,861,000 | $8,954,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 122,000 | 115,000 | 1,000 | 30,000 | 67,000 |
| PPE Investments | -1,764,000 | -1,078,000 | -428,000 | -1,869,000 | -1,163,000 |
| Net Acquisitions | -60,000 | -629,000 | -362,000 | -3,779,000 | -2,771,000 |
| Purchase Of Investment | -228,000 | -188,000 | N/A | -254,000 | -254,000 |
| Sale Of Investment | N/A | N/A | N/A | 91,000 | 86,000 |
| Purchase Sale Intangibles | -2,748,000 | -1,709,000 | -531,000 | -2,539,000 | -2,308,000 |
| Other Investing Activity | -3,432,000 | -1,581,000 | -464,000 | -2,199,000 | -2,764,000 |
| Investing Cash Flow | $-5,362,000 | $-3,361,000 | $-1,253,000 | $-7,980,000 | $-6,799,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,382,000 | 1,734,000 | 1,099,000 | -31,000 | 572,000 |
| Debt Issued | 9,000 | 9,000 | N/A | 6,492,000 | 6,492,000 |
| Debt Repayment | -20,000 | -16,000 | -4,000 | -4,652,000 | -4,647,000 |
| Common Stock Issued | 17,000 | 12,000 | 8,000 | 38,000 | 15,000 |
| Common Stock Repurchased | -508,000 | -489,000 | -486,000 | -81,000 | -81,000 |
| Dividend Paid | -4,968,000 | -3,357,000 | -3,347,000 | -4,629,000 | -4,626,000 |
| Other Financing Activity | -174,000 | -82,000 | 23,000 | -1,133,000 | -1,050,000 |
| Financing Cash Flow | $-4,262,000 | $-2,189,000 | $-2,707,000 | $-3,996,000 | $-3,325,000 |
| Exchange Rate Effect | 42,000 | 54,000 | 25,000 | -93,000 | -32,000 |
| Beginning Cash Position | 5,429,000 | 5,429,000 | 5,429,000 | 5,637,000 | 5,637,000 |
| End Cash Position | 8,080,000 | 7,032,000 | 5,207,000 | 5,429,000 | 4,435,000 |
| Net Cash Flow | $2,651,000 | $1,603,000 | $-222,000 | $-208,000 | $-1,202,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,233,000 | 7,099,000 | 3,713,000 | 11,861,000 | 8,954,000 |
| Capital Expenditure | -1,774,000 | -1,088,000 | -429,000 | -1,924,000 | -1,216,000 |
| Free Cash Flow | 10,459,000 | 6,011,000 | 3,284,000 | 9,937,000 | 7,738,000 |